| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| albumininfusionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| humant albumin 20 % infusionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| humant albumin 4,5 % infusionsvæske, opløsning, flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| anti-D (Rh) immunglobulin injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| anti-D (Rh) immunglobulin 1250 IE/ml injektionsvæske, opløsning, 1 ml i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| anti-D (Rh) immunglobulin 250 IE injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| anti-D (Rh) immunglobulin 500 IE injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| anti-D (Rh) immunglobulin 2500 IE injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| anti-D (Rh) immunglobulin 5000 IE injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| anti-D (Rh) immunglobulin 600 IE pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| anti-D (Rh) immunglobulin 1500 IE pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| Transfusion of whole blood |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Acset |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| blodderivatprodukt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| højrenset faktor IX |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| intermediat faktor IX |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| Product containing anti-inhibitor coagulant complex (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| faktor IX-koncentrat-produkt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| faktor V-koncentrat-produkter |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| faktor VII-koncentrat-produkter |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| DNA-faktor VIII |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| højrenset faktor VIII |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| intermediat faktor VIII |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| Product containing porcine factor VIII (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| Coagulation factor II- and coagulation factor IX- and coagulation factor VIIa- and coagulation factor VIII- and coagulation factor X-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| Product containing coagulation factor XI (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| Fresh frozen plasma |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| Product containing von Willebrand factor (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| antitrombin III 250 IE injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| antitrombin III 500 IE injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| antitrombin III 1000 IE injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| tørret og varmebehandlet faktor IX-fraktion 600 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| faktor VIII-bypassing-fraktion 500 IE, pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| faktor VIII-bypassing fraktion 1000 IE, pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| højrenset faktor VIII-fraktion 250 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| højrenset faktor VIII-fraktion 500 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| højrenset faktor VIII-fraktion 1000 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| intermediat faktor VIII-fraktion 250 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| intermediat faktor VIII-fraktion 500 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| porcin faktor VIII 700 IE, pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| højrenset faktor IX 250 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| højrenset faktor IX 500 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| højrenset faktor IX 1000 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| koagulationsfaktor |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| højrenset faktor IX 1500 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| varmebehandlet humant faktor IX, pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| højrenset faktor VIII-fraktion 350 IE, pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| Treated plasma product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| Solvent+detergent (SD) treated Frozen Human Plasma intravenous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| Cellular blood product, human |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| Tissue specimen obtained for Hodgkin's disease by biopsy |
Specimen substance (attribute) |
False |
Blood |
Inferred relationship |
Some |
|
| Lymph node from axillary dissection (specimen) |
Specimen substance (attribute) |
False |
Blood |
Inferred relationship |
Some |
|
| Lymph node from sentinel lymph node dissection (specimen) |
Specimen substance (attribute) |
False |
Blood |
Inferred relationship |
Some |
|
| plasmaproteinfraktion 5 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| humant albumin 25 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| ioderet albumin ^125^I, serum, 10 mg, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| Product containing precisely hemin 313 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| Lymph node from sentinel lymph node dissection and axillary dissection (specimen) |
Specimen substance (attribute) |
False |
Blood |
Inferred relationship |
Some |
|
| humant albumin 5 % infusionsvæske, opløsning, flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| Biological active component+thrombin sealant solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| Antithrombin III 600iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| Rh anti-D immunglobulin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| Transfusion of packed red blood cells |
Direct substance |
True |
Blood |
Inferred relationship |
Some |
2 |
| Human cryoprecipitate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| Human plasma, blood product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| Product containing human serum albumin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| Human whole blood product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| Frozen red blood cells, human |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| Animal plasma fraction |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| Animal serum globulin preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood |
Inferred relationship |
Some |
|
| Capillary specimen collection |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Pancreatic venous sampling |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Renal venous sampling (procedure) |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Renal transplant venous sampling |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Petrosal sinus sampling catheter procedure |
Direct substance |
True |
Blood |
Inferred relationship |
Some |
1 |
| Simultaneous sampling of bilateral inferior petrosal sinuses (procedure) |
Direct substance |
True |
Blood |
Inferred relationship |
Some |
1 |
| Jugular vein sampling catheter procedure |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Portal venous sampling catheter |
Direct substance |
True |
Blood |
Inferred relationship |
Some |
1 |
| Adrenal vein sampling catheter procedure (procedure) |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Gonadal vein sampling catheter procedure |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Parathyroid sampling catheter procedure |
Direct substance |
True |
Blood |
Inferred relationship |
Some |
1 |
| Thumb-prick sampling |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Blood sampling from extracorporeal blood circuit |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Blood sampling from hemodialysis circuit |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Arterial port blood sampling during hemodialysis |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Venous port blood sampling during haemodialysis |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Blood sampling from cardiopulmonary bypass circuit |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Blood sampling from extracorporeal membrane oxygenation circuit (procedure) |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Finger-prick sampling (procedure) |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Therapeutic phlebotomy |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Therapeutic phlebotomy in laboratory |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Arterial specimen collection for laboratory test |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Radial artery puncture for laboratory test |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Ear lobe stick |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Brachial artery puncture for laboratory test |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Femoral artery puncture for laboratory test |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Therapeutic phlebotomy at bedside |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Heel stick |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Collection of blood specimen for laboratory |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Other specified blood withdrawal |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
| Blood withdrawal NOS |
Direct substance |
False |
Blood |
Inferred relationship |
Some |
1 |
FHIR